TD Ameritrade Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30
Closed -$4K 534
2023
Q2
$4K Sell
30
-4
-12% -$544 ﹤0.01% 419
2023
Q1
$4K Buy
34
+2
+6% +$251 ﹤0.01% 444
2022
Q4
$4K Sell
32
-8
-20% -$928 ﹤0.01% 450
2022
Q3
$4K Sell
40
-66
-62% -$7.24K ﹤0.01% 454
2022
Q2
$11K Sell
106
-101
-49% -$12K ﹤0.01% 429
2022
Q1
$26K Buy
207
+12
+6% +$1.45K ﹤0.01% 401
2021
Q4
$24K Buy
195
+38
+24% +$4.97K ﹤0.01% 401
2021
Q3
$21K Sell
157
-17
-10% -$2.5K ﹤0.01% 389
2021
Q2
$27K Buy
174
+19
+12% +$3.08K ﹤0.01% 382
2021
Q1
$23K Hold
155
﹤0.01% 392
2020
Q4
$23K Sell
155
-2
-1% -$282 ﹤0.01% 392
2020
Q3
$21K Buy
157
+5
+3% +$653 ﹤0.01% 389
2020
Q2
$18K Hold
152
﹤0.01% 386
2020
Q1
$15K Buy
152
+35
+30% +$4.59K ﹤0.01% 380
2019
Q4
$17K Buy
117
+67
+134% +$9.25K ﹤0.01% 406
2019
Q3
$7K Sell
50
-2
-4% -$258 ﹤0.01% 487
2019
Q2
$6K Sell
52
-7
-12% -$820 ﹤0.01% 478
2019
Q1
$7K Sell
59
-29
-33% -$3.3K ﹤0.01% 412
2018
Q4
$9K Sell
88
-4
-4% -$450 ﹤0.01% 370
2018
Q3
$12K Buy
92
+53
+136% +$6.3K ﹤0.01% 318
2018
Q2
$4K Buy
+39
New +$4.25K ﹤0.01% 289

Other funds holding ZBH

TD Ameritrade Investment Management's ZBH Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 30 shares — an estimated $4K sold.

TD Ameritrade Investment Management first reported a position in ZBH in Q2 2018 and held it in 21 quarters. The position peaked at $27K in Q2 2021. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 30 Zimmer Biomet shares in Q3 2023, an estimated $4K.
  • TD Ameritrade Investment Management first reported a position in Zimmer Biomet in Q2 2018 and held it in 21 quarters.
  • TD Ameritrade Investment Management's Zimmer Biomet position peaked at $27K in Q2 2021.
  • 1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.